Draegerwerk AG KGaAXSWX:DRW3 75 Return-on-Tangible-Asset is 1.60% as of Mar. 2026, which is 63% below its 10-year median of 4.35. GuruFocus rates XSWX:DRW3 with a GF Score™ of 75/100 and a GF Value™ of CHF54.56. The stock has 3 warning signs investors should review. Among 857 Medical Devices & Instruments companies, Draegerwerk AG KGaA ranks better than 67.44% on this metric.
Return-on-Tangible-Asset is calculated as Net Income divided by its average total tangible assets. Total tangible assets equals to Total Assets minus Intangible Assets. Draegerwerk AG KGaA's annualizedNet Income for the quarter that ended in Mar. 2026 was CHF42 Mil. Draegerwerk AG KGaA's average total tangible assets for the quarter that ended in Mar. 2026 was CHF2,610 Mil. Therefore, Draegerwerk AG KGaA's annualized Return-on-Tangible-Asset for the quarter that ended in Mar. 2026 was 1.60%.
The historical rank and industry rank for Draegerwerk AG KGaA's Return-on-Tangible-Asset or its related term are showing as below:
XSWX:DRW3'
s Return-on-Tangible-Asset Range Over the Past 10 Years
Min: -2.31 Med: 4.35 Max: 9.6
Current: 5.57
During the past 13 years, Draegerwerk AG KGaA's highest Return-on-Tangible-Asset was 9.60%. The lowest was -2.31%. And the median was 4.35%.
XSWX:DRW3's Return-on-Tangible-Asset is ranked better than 67.44% of 857
companies
in the Medical Devices & Instruments industry
Industry Median: 0.57
vs XSWX:DRW3: 5.57
Draegerwerk AG KGaA (XSWX:DRW3) Return-on-Tangible-Asset Explanation
Return-on-Tangible-Asset measures the rate of return on the average total tangible assets (total assets minus intangible assets). Tangible means physical in nature. Intangible Assets are assets that are not physical in nature, and typically "derive their value from legal or intellectual rights." Return-on-Tangible-Asset measures a firm's efficiency at generating profits from its tangible assets. It shows how well a company uses what it has to generate earnings. Return-on-Tangible-Assets can vary drastically across industries. Therefore, Return-on-Tangible-Asset should not be used to compare companies in different industries.
Be Aware
Like ROE and ROA, Return-on-Tangible-Asset is calculated with only 12 months data. Fluctuations in the companys earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. Return-on-Tangible-Asset can be affected by events such as stock buyback or issuance, and by a companys tax rate and its interest payment. Return-on-Tangible-Asset may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).
Many analysts argue the higher return the better. Buffett states that really high Return-on-Tangible-Asset may indicate vulnerability in the durability of the competitive advantage.
Draegerwerk AG KGaA Return-on-Tangible-Asset Related Terms
Draegerwerk AG KGaA Return-on-Tangible-Asset Historical Data
* Premium members only.
The historical data trend for Draegerwerk AG KGaA's Return-on-Tangible-Asset can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Draegerwerk AG KGaA Return-on-Tangible-Asset Chart
XSWX:DRW3 vs ABT, SYK, MDT: Return-on-Tangible-Asset Comparison
For the Medical Devices subindustry, Draegerwerk AG KGaA's Return-on-Tangible-Asset, along with its competitors' market caps and Return-on-Tangible-Asset data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Draegerwerk AG KGaA Return-on-Tangible-Asset vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Draegerwerk AG KGaA's Return-on-Tangible-Asset distribution charts can be found below:
* The bar in red indicates where Draegerwerk AG KGaA's Return-on-Tangible-Asset falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Return-on-Tangible-Asset, the net income of the last fiscal year and the average total tangible assets over the fiscal year are used. In calculating the quarterly data,
the Net Income data used here is four times the quarterly (Mar. 2026) net income data.
What does a Return-on-Tangible-Asset of 1.60% mean?
Draegerwerk AG KGaA (XSWX:DRW3) has a Return-on-Tangible-Asset of 1.60% as of Mar. 2026. Return on tangible assets is the ratio of current-period net income to average two-period tangible assets. View historical data on Draegerwerk AG KGaA and its competitors. This is 63% below median its historical median of 4.35. According to the industry distribution chart, Draegerwerk AG KGaA ranks #279 out of 857 companies in the Medical Devices & Instruments industry, placing it in the top 32.6%.
Is Draegerwerk AG KGaA's Return-on-Tangible-Asset too high?
Draegerwerk AG KGaA's current Return-on-Tangible-Asset of 1.60% is 63% below median its 10-year median of 4.35. The Medical Devices & Instruments industry median Return-on-Tangible-Asset is 0.57. Draegerwerk AG KGaA's value of 1.60% is 180.7% above this industry median. Based on the distribution chart, Draegerwerk AG KGaA ranks #279 out of 857 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Draegerwerk AG KGaA has a GF Score™ of 75/100, reflecting its overall financial health beyond just this single metric.
How does Draegerwerk AG KGaA's Return-on-Tangible-Asset compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Draegerwerk AG KGaA ranks #279 out of 857 companies for Return-on-Tangible-Asset. This puts Draegerwerk AG KGaA in the upper half of its industry. The industry median Return-on-Tangible-Asset is 0.57. Draegerwerk AG KGaA's value of 1.60% is 180.7% above this benchmark. While the company's 10-year median is 4.35 vs. the industry median of 0.57, Draegerwerk AG KGaA has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Return-on-Tangible-Asset for a Medical Devices & Instruments company?
The median Return-on-Tangible-Asset among Medical Devices & Instruments companies is 0.57, based on 857 companies in the industry. Companies in the top quartile (top 25%) have a Return-on-Tangible-Asset significantly above this median, while those in the bottom quartile fall well below. However, Return-on-Tangible-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Draegerwerk AG KGaA's current Return-on-Tangible-Asset of 1.60% is 180.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Return-on-Tangible-Asset mean?
A high Return-on-Tangible-Asset can signal that a stock is expensive relative to its fundamentals. Return on tangible assets is the ratio of current-period net income to average two-period tangible assets. View historical data on Draegerwerk AG KGaA and its competitors. For the Medical Devices & Instruments industry, the median Return-on-Tangible-Asset is 0.57 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Draegerwerk AG KGaA's current Return-on-Tangible-Asset is 1.60%, which is 63% below median its own 10-year median of 4.35. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Draegerwerk AG KGaA stock overvalued right now?
Draegerwerk AG KGaA (XSWX:DRW3) has a current Return-on-Tangible-Asset of 1.60%. The stock's GF Value™ is CHF54.56, compared to a current price of CHF78.20 — trading 43.3% above its estimated fair value. The current Return-on-Tangible-Asset is 1.60%, which is 63% below median its 10-year median of 4.35 and 180.7% above the Medical Devices & Instruments industry median of 0.57. Draegerwerk AG KGaA's overall GF Score™ is 75/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Return-on-Tangible-Asset calculated?
Return-on-Tangible-Asset is calculated from a company's financial statements. For Draegerwerk AG KGaA (XSWX:DRW3), the current Return-on-Tangible-Asset is 1.60% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Draegerwerk AG KGaA (XSWX:DRW3) Overvalued in 2026?
Based on GuruFocus' analysis, Draegerwerk AG KGaA stock appears to be overvalued.
The current stock price of CHF78.20 is trading 43.3% above its estimated GF Value™ of CHF54.56.
Key valuation signals for XSWX:DRW3:
Return-on-Tangible-Asset: 1.60% (63% below median its 10-year median of 4.35)
GF Value™: CHF54.56 vs. price of CHF78.20 (43.3% above fair value)
Industry Position: 180.7% above the Medical Devices & Instruments median (#279 of 857)
No single metric tells the full story. See the XSWX:DRW3 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Draegerwerk AG & Co KGaA develops medical and safety equipment for clinical and industrial applications. The firm operates in two segments: medical and safety. The medical division contributes the majority of revenue, it develops and produces system solutions, equipment, and services for the acute point of care, it has five business units Therapy, Hospital Consumables & Accessories, Workplace Infrastructure, Monitoring, and Data Business. Its safety division develops and produces devices, system solutions, and services for personal protection, gas detection, and integrated hazard management. Its geographical segments are Europe; Germany; the Americas; Africa, Asia, and Australia.
75GF Score
Get the complete analysis for XSWX:DRW3
Return-on-Tangible-Asset is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XSWX:DRW3 has been successfully added to your 
